Theralase Technologies: Funding, Investors & Team (Sep 2026)
Theralase Technologies is a biopharmaceutical company that specializes in creating and selling patented laser technology for various medical applications. The company has two divisions: one focuses on producing therapeutic laser technology for commercial use, while the other focuses on researching and developing laser-based technologies for cancer cell destruction and other health conditions. The Therapeutic Laser Technology division works on creating non-invasive devices to treat pain, inflammation, and promote tissue healing. The Photo Dynamic Therapy division focuses on developing light-activated molecules and laser systems with strong anti-cancer and microbial sterilization properties.
Theralase Technologies has raised $7.0M across 6 funding rounds on record, the most recent an undisclosed round of $3.4M announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Theralase Technologies Company Profile and Key Stats
Latest funding round on record: May 2026.
Theralase Technologies Funding Rounds
Theralase Technologies raised $210k in an undisclosed round announced in Mar 2025.
3 months later, an undisclosed round of $420k was announced in Jun 2025.
6 months later, an undisclosed round of $970k was announced in Dec 2025.
3 months later, an undisclosed round of $810k was announced in Mar 2026.
1 month later, an undisclosed round of $1.2M was announced in Apr 2026.
1 month later, an undisclosed round of $3.4M was announced in May 2026.
Theralase Technologies Founders and Leadership Team
Contact details for the Theralase Technologies team: 1 of 2 have an email address on file.
Start 14-day free trial →Theralase Technologies Funding Compared to Other Biotechnology Startups
Theralase Technologies' latest round of $3.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Theralase Technologies in Biotechnology and Toronto
Companies Similar to Theralase Technologies
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Theralase Technologies Funding FAQs
What does Theralase Technologies do?
Theralase Technologies is a biopharmaceutical company that specializes in creating and selling patented laser technology for various medical applications. The company has two divisions: one focuses on producing therapeutic laser technology for commercial use, while the other focuses on researching and developing laser-based technologies for cancer cell destruction and other health conditions. The Therapeutic Laser Technology division works on creating non-invasive devices to treat pain, inflammation, and promote tissue healing. The Photo Dynamic Therapy division focuses on developing light-activated molecules and laser systems with strong anti-cancer and microbial sterilization properties.
How much funding has Theralase Technologies raised?
Theralase Technologies has raised $7.0M across 6 rounds on record. The most recent is an undisclosed round of $3.4M announced in May 2026.
When did Theralase Technologies last raise funding?
Theralase Technologies' most recent funding round on record is an undisclosed round of $3.4M, announced in May 2026.
Who founded Theralase Technologies?
FundedIQ lists Roger Dumoulin (Founder), Roger Dumoulin White (Founder) at Theralase Technologies.
Where is Theralase Technologies headquartered?
Theralase Technologies is based in Toronto, Ontario, Canada.
How many employees does Theralase Technologies have?
Theralase Technologies is in the 11-50 employee band.
How does Theralase Technologies' funding compare to other Biotechnology startups?
Theralase Technologies' latest round of $3.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Theralase Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Theralase Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.